Associate Professor, Medicine - Blood and Marrow Transplantation, Stanford University Medical Center
Hematology
Dr. Robert Lowsky, MD
|
|
Give Review
Robert Lowsky practices Hematology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Robert Lowsky, MD is also published. He has 38 publications published. The lastest publication: "Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.' He accepts Medicare.
Publications
- Risks and benefits of sex-mismatched hematopoietic Cell transplantation differ according to conditioning strategy.
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with Myelodysplastic syndromes and myeloproliferative neopla...
- Identification of gene microarray expression profiles in patients with Chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation.
- European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with Acute myeloid leukemia undergoing allogeneic hematopoiet...
- Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous Leukemia developing after initiation of interferon and cytosine arabinoside.
- MSH2-deficient murine Lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency micr...
- Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
- Cloning, expression, and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene, hLim-1.
- Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic Leukemia.
- Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic Lymphomas and are associated with the aberrant expression ...
- Detection of donor cell derived Acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
- Familial visceral myopathy associated with a mitochondrial myopathy.
- Secondary malignancies after bone marrow transplantation in adults.
- Brief report: diagnosis of Whipple's Disease by molecular analysis of peripheral blood.
- A granulosa Cell differentiation-stage-specific cytotoxic activity in bovine and rat sera.
- Adult T-cell leukemia/lymphoma presenting as an Acute noninfectious pneumonitis.
- Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation.
- Translational studies in hematopoietic Cell transplantation: Treatment of hematologic malignancies as a stepping stone to tolerance induction.
- Adoptive immunotherapy with cytokine-induced killer Cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic Cell transplantation.
- NKT Cells, Treg, and their interactions in bone marrow transplantation.
- Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk Chronic lymphocytic leukaemia.
- Long-term outcomes in patients with high-risk Myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning o...
- Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic Cell transplantation in recurrent and refractory...
- Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update.
- Long-term follow-up of patients with diffuse large B-cell non-Hodgkin''s Lymphoma receiving purged autografts after induction failure.
- Total lymphoid irradiation for graft-versus-host Disease protection.
- TLI and ATG conditioning with low risk of graft-versus-host Disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and un...
- Tolerance and chimerism after renal and hematopoietic-Cell transplantation.
- RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid Leukemia cell lines.
- High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin Lymphoma.
- Protective conditioning for Acute graft-versus-host disease.
- Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple Myeloma.
- A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies.
- CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host Disease, or survival following myeloablative human leukocyte antigen-identical peripheral...
- Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic Cell transplantation is affected by CD8+ T-Cell dose.
- Short tandem repeat analysis to monitor chimerism in macaca fascicularis.
- Approaches to transplantation tolerance in humans.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicaid
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1083756308 | |
| NPPES Provider LastName | LOWSKY | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 167.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083756308 |
| Last Name Of The Provider | LOWSKY |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Judith A. Shizuru, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Daniel Arber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hywyn R. Churchill, MD |
|
|
Dr. Linda M. Boxer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kitsada Wudhikarn, MD |
|
|
Dr. David B. Miklos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Chan, MD |
|
|
Dr. Robert W. Hsieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marisa M. Juntilla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Cascio, MD
This Doctor is OpenDoctor Recommended.
|